JOHN C MARTIN Insider Trading $KRON Kronos Bio, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN C MARTIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN C MARTIN. JOHN C MARTIN is Chairman and CEO in GILEAD SCIENCES INC ($GILD) and Director in GILEAD SCIENCES INC ($GILD) and Executive Chairman in GILEAD SCIENCES INC ($GILD) and President and CEO in GILEAD SCIENCES INC ($GILD) and Director in Sarepta Therapeutics, Inc. ($SRPT) and Director in Kronos Bio, Inc. ($KRON).
JOHN C MARTIN in Kronos Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN C MARTIN: Director
Holdings: 914,333 shares
Latest Transaction: Oct 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN C MARTIN in Kronos Bio, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GILD, KRON, SRPT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Option Exercise | C | 0.00 | 717,509 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Option Exercise | C | 0.00 | 866,667 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | P | 19.00 | 75,800 | 1,440,200 | 1,952,364 | 1.9 M to 2 M (+4.04 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Option Exercise | C | 0.00 | 717,509 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | C | 16.15 | 205,260 | 3,314,949 | 1,876,564 | 1.7 M to 1.9 M (+12.28 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Option Exercise | C | 0.00 | 866,667 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | C | 0.00 | 756,971 | 0 | 1,671,304 | 914.3 K to 1.7 M (+82.79 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | P | 19.00 | 75,800 | 1,440,200 | 1,952,364 | 1.9 M to 2 M (+4.04 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | C | 0.00 | 914,333 | 0 | 914,333 | 0 to 914.3 K |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | C | 16.15 | 205,260 | 3,314,949 | 1,876,564 | 1.7 M to 1.9 M (+12.28 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | C | 0.00 | 756,971 | 0 | 1,671,304 | 914.3 K to 1.7 M (+82.79 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | C | 0.00 | 914,333 | 0 | 914,333 | 0 to 914.3 K |
Page: 1